Oncology

HIF-2 inhibitors may be better tolerated and more effective in kidney cancer.

Bristol-Myers Squibb employees will cycle across the US to raise awareness for cancer research.

Inhibiting immune cells’ oxygen-sensing capability prevented lung metastasis in mice.

The median charge of treatment for a 6-day hospital stay totals $37,000 in young cancer patients in need of stem cell transplants.

Chromosomal instability may be a potential biomarker for cancer prognosis.

The revolutionary CRISPR/Cas9 gene editing tool can target and inactivate cancer mutations, leading to more personalized therapies for patients.

Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses the components of an effective patient management program to optimize adherence.

Pembrolizumab (Keytruda) was previously granted Breakthrough Therapy Designation for advanced non-small cell lung cancer.

A Supplemental Biologics License Application was submitted for Keytruda for the treatment of lung cancer.

Preventative strategies necessary to reduce hospital admissions resulting from cancer treatments, medical complications, accidents, and self-harm.

Selective manipulation of an enzyme can stop cancer cachexia.

Vitamin A metabolite in the gut kills off cancer cells.

Immunotherapy able to kill triple-negative breast cancer cells via two-pronged strategy.

Higher levels of transport genes are an indicator of patients likely to be resistant to therapy with tamoxifen.

Top news of the week in oncology, and cancer drug development.

Experimental drug shows promise killing triple negative breast cancer cells.

Hepatitis C causes inflexible scar tissue to form in the liver.

Atezolizumab (Tecentriq) monoclonal antibody that binds to the PD-L1 protein in non-small cell lung cancer.

New treatment for mast cell leukemia could improve quality-of-life and overall survival.

Xalkori received approval for ROS1-positive advanced non-small cell lung cancer.

Several mechanisms can lead to BRAF inhibitor resistance among patients with melanoma.

Top news of the day from across the health care landscape.

Lymph node staging carries a clinical significance in lung cancer patients.

Direct-acting antivirals can cure hepatitis C in most patients, but the drugs don’t eliminate complications, such as cirrhosis and liver cancer.

Little clinical data exists to aid shared decision making for mammography frequency.

Research targets formation of esophageal cancer tumors.

Nebivolol shows promise blocking anthracycline-induced cardiotoxicity in breast cancer patients.

Research reveals potential drug targets for cervical cancer associated with human papillomavirus.